Teamshares is an employee ownership platform tailored for small businesses, utilizing proprietary software, education, and financial products. Acknowledging small businesses as economic powerhouses and community pillars, Teamshares aims to ensure their continuity. The goal is to build a network of 10,000 financially durable, employee-owned small businesses across America, fostering a new era of business ownership and financial resilience.

Register for Details

For more details on financing and valuation for Verge Genomics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Verge Genomics

To invest in Verge Genomics pre-IPO

Can you invest in Verge Genomics pre-IPO?

Verge Genomics is a privately held company and is not publicly traded, therefore investing in Verge Genomics pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Verge Genomics before it goes public?

You can seek to sell your shares in Verge Genomics while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Verge Genomics shares?

To determine the value of your Verge Genomics shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Verge Genomics shares. You can also learn more about how to sell your private shares before getting started.

Is Verge Genomics a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Verge Genomics potential IPO

Will Verge Genomics go IPO?

Verge Genomics has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Verge Genomics’ IPO price?

The Verge Genomics IPO price does not exist at this time, as Verge Genomics is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Verge Genomics register for Forge Markets, today.

When was Verge Genomics founded?

Verge Genomics was founded in 2015.

What is Verge Genomics funding to date?

Verge Genomics has raised $180.65MM to date.

Who are Verge Genomics’s major investors?

Karlin Venture
Eli Lilly
Two Sigma Ventures
Draper Associates
David Lee
Dfj
Y Combinator
Alexion
Vulcan Capital
Elad Gil
Wuxi Apptec
Slow Ventures
Lifeforce Capital
Tao Capital Partners
Als Investment Fund
Threshold Ventures
Section 32
Agent Capital
Blackrock
Great Oaks Vc
Tenmile
Astrazeneca
Os Fund
Merck
IA Ventures
Alumni Ventures

Verge Genomics Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
09/08/2023 Series C $42MM $xx.xx $406.6MM Alexion, AstraZeneca, Alumni Ventures, Tenmile
Price per Share
$xx.xx
Shares Outstanding
5,840,472
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Alexion, AstraZeneca, Alumni Ventures, Tenmile
02/16/2021 Series B-1 $85MM $xx.xx $272.98MM BlackRock, Eli Lilly, Merck, Section 32, Vulcan Capital, Threshold Ventures, ALS Investment Fund, Tao Capital Partners, Lifeforce Capital
Price per Share
$xx.xx
Shares Outstanding
15,957,045
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
BlackRock, Eli Lilly, Merck, Section 32, Vulcan Capital, Threshold Ventures, ALS Investment Fund, Tao Capital Partners, Lifeforce Capital
07/16/2018 Series A-1 $45.12MM $xx.xx $104.52MM DFJ, WuXi AppTec, ALS Investment Fund, Agent Capital, OS Fund
Price per Share
$xx.xx
Shares Outstanding
13,622,216
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
DFJ, WuXi AppTec, ALS Investment Fund, Agent Capital, OS Fund
11/03/2015 Series A-3 $3.41MM $xx.xx $21.97MM IA Ventures, Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Venture, Elad Gil, David Lee
Price per Share
$xx.xx
Shares Outstanding
1,480,221
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
IA Ventures, Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Venture, Elad Gil, David Lee
11/03/2015 Series A-2 $4.5MM $xx.xx $21.97MM IA Ventures, Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Venture, Elad Gil, David Lee
Price per Share
$xx.xx
Shares Outstanding
1,698,104
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
IA Ventures, Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Venture, Elad Gil, David Lee
07/21/2015 Series A-6 $369,998 $xx.xx $2.63MM Y Combinator
Price per Share
$xx.xx
Shares Outstanding
367,098
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Y Combinator
07/21/2015 Series A-5 $149,999 $xx.xx $2.63MM Y Combinator
Price per Share
$xx.xx
Shares Outstanding
115,758
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Y Combinator
07/21/2015 Series A-4 $99,998 $xx.xx $2.63MM Y Combinator
Price per Share
$xx.xx
Shares Outstanding
70,155
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Y Combinator
Updated on: Nov 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.